Resultados de procura - J. Andrea McCart
- Mostrando 1 - 19 Resultados de 19
-
1
-
2
-
3
A contemporary analysis of morbidity and outcomes in cytoreduction/hyperthermic intraperitoneal chemoperfusion por Michelle Haslinger, Valerie Francescutti, Kristopher Attwood, J. Andrea McCart, Marwan Fakih, John M. Kane, Joseph J. Skitzki
Publicado 2013Artigo -
4
Intravenously Administered Alphavirus Vector VA7 Eradicates Orthotopic Human Glioma Xenografts in Nude Mice por Jari Heikkilä, Markus Vähä‐Koskela, Janne Ruotsalainen, Miika Martikainen, Marianne M. Stanford, J. Andrea McCart, John C. Bell, Ari Hinkkanen
Publicado 2010Artigo -
5
Evidence for differential viral oncolytic efficacy in an in vitro model of epithelial ovarian cancer metastasis por Jessica Tong, Yudith Ramos Valdés, John W. Barrett, John C. Bell, David F. Stojdl, Grant McFadden, J. Andrea McCart, Gabriel E. DiMattia, Trevor G. Shepherd
Publicado 2015Artigo -
6
Efficacy of Systemically Administered Oncolytic Vaccinia Virotherapy for Malignant Gliomas Is Enhanced by Combination Therapy with Rapamycin or Cyclophosphamide por Xue Qing Lun, Ji-Hyun Jang, Nan Tang, Helen Deng, Renee Head, John C. Bell, David F. Stojdl, Catherine L. Nutt, Donna L. Senger, Peter Forsyth, J. Andrea McCart
Publicado 2009Artigo -
7
Oncolytic virotherapy for ovarian carcinomatosis using a replication-selective vaccinia virus armed with a yeast cytosine deaminase gene por Sricharan Chalikonda, Maryann H. Kivlen, Mark E. O’Malley, Xiaopeng Dong, J. Andrea McCart, Michael Gorry, X-Y Yin, Charlie Brown, Herbert J. Zeh, Zong Sheng Guo, David L. Bartlett
Publicado 2007Artigo -
8
Phase 1 Study of Intravenous Oncolytic Poxvirus (vvDD) in Patients With Advanced Solid Cancers por Stephanie Downs‐Canner, Zong Sheng Guo, Roshni Ravindranathan, Caroline J. Breitbach, Mark E. O’Malley, Heather Jones, Anne Moon, J. Andrea McCart, Yongli Shuai, Herbert J. Zeh, David L. Bartlett
Publicado 2016Artigo -
9
Oncolytic Vaccinia Virus Expressing the Human Somatostatin Receptor SSTR2: Molecular Imaging after Systemic Delivery Using 111In-Pentetreotide por J. Andrea McCart, Navneet Mehta, Deborah A. Scollard, Raymond M. Reilly, Jorge A. Carrasquillo, Nan Tang, Hui Deng, Marshall Miller, Hui Xu, Steven K. Libutti, H. Richard Alexander, David L. Bartlett
Publicado 2004Artigo -
10
Antiangiogenic Arming of an Oncolytic Vaccinia Virus Enhances Antitumor Efficacy in Renal Cell Cancer Models por Kilian Guse, Marta Słoniecka, Iulia Diaconu, Kathryn Ottolino‐Perry, Nan Tang, Calvin S.H. Ng, Fabrice Le Bœuf, John C. Bell, J. Andrea McCart, Ari Ristimäki, Sari Pesonen, Vincenzo Cerullo, Akseli Hemminki
Publicado 2009Artigo -
11
Guidelines on the Use of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in Patients with Peritoneal Surface Malignancy Arising from Colorectal or Appendiceal N... por Pierre‐André Dubé, Lucas Sidéris, Calvin Law, Lloyd A. Mack, Erika Haase, Carman A. Giacomantonio, Anand Govindarajan, Monika K. Krzyzanowska, Pierre Major, Yarrow J. McConnell, Walley Temple, Rami Younan, J. Andrea McCart
Publicado 2015Artigo -
12
Targeted Inflammation During Oncolytic Virus Therapy Severely Compromises Tumor Blood Flow por Caroline J. Breitbach, Jennifer M Paterson, Chantal G. Lemay, Theresa Falls, Allison McGuire, Kelley A. Parato, David F. Stojdl, Manijeh Daneshmand, Kelly Speth, David H. Kirn, J. Andrea McCart, Harold Atkins, John C. Bell
Publicado 2007Artigo -
13
Synergistic Interaction Between Oncolytic Viruses Augments Tumor Killing por Fabrice Le Bœuf, Jean‐Simon Diallo, J. Andrea McCart, Steve H. Thorne, Theresa Falls, Marianne M. Stanford, Femina Kanji, Rebecca C. Auer, Chris W. Brown, Brian D. Lichty, Kelley A. Parato, Harold Atkins, David H. Kirn, John C. Bell
Publicado 2010Artigo -
14
Enhancement of Vaccinia Virus Based Oncolysis with Histone Deacetylase Inhibitors por Heather MacTavish, Jean‐Simon Diallo, Baocheng Huang, Marianne M. Stanford, Fabrice Le Bœuf, Naomi De Silva, Julie A. Cox, John-Graydon Simmons, Tanya Guimond, Theresa Falls, J. Andrea McCart, Harry Atkins, Caroline J. Breitbach, David H. Kirn, Stephen H. Thorne, John C. Bell
Publicado 2010Artigo -
15
Oncolytic Vaccinia Virus Disrupts Tumor-Associated Vasculature in Humans por Caroline J. Breitbach, Rozanne Arulanandam, Naomi De Silva, Steve H. Thorne, Richard H. Patt, Manijeh Daneshmand, Anne Moon, Carolina S. Ilkow, James M. Burke, Tae-Ho Hwang, Jeong Heo, Mong Cho, Hannah Chen, Fernando A. Angarita, Christina Addison, J. Andrea McCart, John C. Bell, David H. Kirn
Publicado 2013Artigo -
16
First-in-man Study of Western Reserve Strain Oncolytic Vaccinia Virus: Safety, Systemic Spread, and Antitumor Activity por Herbert J. Zeh, Stephanie Downs‐Canner, J. Andrea McCart, Zong Sheng Guo, Uma N. M. Rao, Lekshmi Ramalingam, Stephen H. Thorne, Heather Jones, Paweł Kaliński, Eva Wieckowski, Mark E. O’Malley, Manijeh Daneshmand, Kang Hu, John C. Bell, Tae-Ho Hwang, Anne Moon, Caroline J. Breitbach, David H. Kirn, David L. Bartlett
Publicado 2014Artigo -
17
Complement Inhibition Prevents Oncolytic Vaccinia Virus Neutralization in Immune Humans and Cynomolgus Macaques por Laura Evgin, Sergio A. Acuña, Christiano Tanese de Souza, Monique Marguerie, Chantal G. Lemay, Carolina S. Ilkow, C. Scott Findlay, Theresa Falls, Kelley A. Parato, David Hanwell, Alyssa Goldstein, Roberto Lopez, Sandra Lafrance, Caroline J. Breitbach, David H. Kirn, Harold Atkins, Rebecca C. Auer, Joshua M. Thurman, Gregory L. Stahl, John D. Lambris, John C. Bell, J. Andrea McCart
Publicado 2015Artigo -
18
VEGF-Mediated Induction of PRD1-BF1/Blimp1 Expression Sensitizes Tumor Vasculature to Oncolytic Virus Infection por Rozanne Arulanandam, Cory Batenchuk, Fernando A. Angarita, Kathryn Ottolino‐Perry, Sophie Cousineau, Amelia Mottashed, Emma Burgess, Theresa Falls, Naomi De Silva, Jovian Tsang, Grant A. Howe, Marie‐Claude Bourgeois‐Daigneault, David P. Conrad, Manijeh Daneshmand, Caroline J. Breitbach, David H. Kirn, Leda Raptis, Subash Sad, Harold Atkins, Michael S. Huh, Jean‐Simon Diallo, Brian D. Lichty, Carolina S. Ilkow, Fabrice Le Bœuf, Christina Addison, J. Andrea McCart, John C. Bell
Publicado 2015Artigo -
19
Preclinical evaluation of a MAGE-A3 vaccination utilizing the oncolytic Maraba virus currently in first-in-human trials por Jonathan Pol, Sergio A. Acuña, Beta Yadollahi, Nan Tang, Kyle B. Stephenson, Matthew J. Atherton, David Hanwell, Alexander O. El‐Warrak, Alyssa Goldstein, Badru Moloo, Patricia V. Turner, Roberto Lopez, Sandra Lafrance, Carole Evelegh, Galina Denisova, Robin Parsons, Jamie Millar, Gautier Stoll, Chantal G. Martin, Julia Pomoransky, Caroline J. Breitbach, Jonathan L. Bramson, John C. Bell, Yonghong Wan, David F. Stojdl, Brian D. Lichty, J. Andrea McCart
Publicado 2018Artigo
Ferramentas de procura:
Materias Relacionadas
Oncolytic virus
Biology
Virology
Virus
Gene
Cancer research
Medicine
Recombinant DNA
Vaccinia
Cancer
Genetics
Biochemistry
Immunology
Internal medicine
Ovarian cancer
Colorectal cancer
Cytoreductive surgery
Genetic enhancement
Oncology
Pathology
Surgery
Virotherapy
Cancer cell
Cell culture
Chemotherapy
Clinical trial
General surgery
Glioma
Hyperthermic intraperitoneal chemotherapy
Immune system